Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

High selective detection of mercury (II) ions by thioether side groups on metal-organic frameworks.

Fu L, Xie K, Wang A, Lyu F, Ge J, Zhang L, Zhang H, Su W, Hou YL, Zhou C, Wang C, Ruan S.

Anal Chim Acta. 2019 Nov 12;1081:51-58. doi: 10.1016/j.aca.2019.06.055. Epub 2019 Jun 28.

PMID:
31446963
2.

Characterization of the ERG-regulated Kinome in Prostate Cancer Identifies TNIK as a Potential Therapeutic Target.

Lee RS, Zhang L, Berger A, Lawrence MG, Song J, Niranjan B, Davies RG, Lister NL, Sandhu SK, Rubin MA, Risbridger GP, Taylor RA, Rickman DS, Horvath LG, Daly RJ.

Neoplasia. 2019 Apr;21(4):389-400. doi: 10.1016/j.neo.2019.02.005. Epub 2019 Mar 20.

3.

Characterization of the Src-regulated kinome identifies SGK1 as a key mediator of Src-induced transformation.

Ma X, Zhang L, Song J, Nguyen E, Lee RS, Rodgers SJ, Li F, Huang C, Schittenhelm RB, Chan H, Chheang C, Wu J, Brown KK, Mitchell CA, Simpson KJ, Daly RJ.

Nat Commun. 2019 Jan 17;10(1):296. doi: 10.1038/s41467-018-08154-1.

4.

In Situ High-Pressure X-ray Diffraction and Raman Spectroscopy Study of Ti3C2Tx MXene.

Zhang L, Su W, Huang Y, Li H, Fu L, Song K, Huang X, Yu J, Lin CT.

Nanoscale Res Lett. 2018 Oct 29;13(1):343. doi: 10.1186/s11671-018-2746-4.

5.

miR106b regulates retinoblastoma Y79 cells through Runx3.

Yang G, Fu Y, Zhang L, Lu X, Li Q.

Oncol Rep. 2017 Nov;38(5):3039-3043. doi: 10.3892/or.2017.5931. Epub 2017 Aug 30.

PMID:
28901461
6.

The kinome 'at large' in cancer.

Fleuren ED, Zhang L, Wu J, Daly RJ.

Nat Rev Cancer. 2016 Feb;16(2):83-98. doi: 10.1038/nrc.2015.18. Review.

PMID:
26822576
7.

The pseudokinase SgK223 promotes invasion of pancreatic ductal epithelial cells through JAK1/Stat3 signaling.

Tactacan CM, Phua YW, Liu L, Zhang L, Humphrey ES, Cowley M, Pinese M, Biankin AV, Daly RJ.

Mol Cancer. 2015 Jul 29;14:139. doi: 10.1186/s12943-015-0412-3.

8.

Profiling the tyrosine phosphoproteome of different mouse mammary tumour models reveals distinct, model-specific signalling networks and conserved oncogenic pathways.

Ali NA, Wu J, Hochgräfe F, Chan H, Nair R, Ye S, Zhang L, Lyons RJ, Pinese M, Lee HC, Armstrong N, Ormandy CJ, Clark SJ, Swarbrick A, Daly RJ.

Breast Cancer Res. 2014 Sep 9;16(5):437. doi: 10.1186/s13058-014-0437-3.

9.

Characterization of the novel broad-spectrum kinase inhibitor CTx-0294885 as an affinity reagent for mass spectrometry-based kinome profiling.

Zhang L, Holmes IP, Hochgräfe F, Walker SR, Ali NA, Humphrey ES, Wu J, de Silva M, Kersten WJ, Connor T, Falk H, Allan L, Street IP, Bentley JD, Pilling PA, Monahan BJ, Peat TS, Daly RJ.

J Proteome Res. 2013 Jul 5;12(7):3104-16. doi: 10.1021/pr3008495. Epub 2013 Jun 25.

PMID:
23692254
10.

Involvement of Lyn and the atypical kinase SgK269/PEAK1 in a basal breast cancer signaling pathway.

Croucher DR, Hochgräfe F, Zhang L, Liu L, Lyons RJ, Rickwood D, Tactacan CM, Browne BC, Ali N, Chan H, Shearer R, Gallego-Ortega D, Saunders DN, Swarbrick A, Daly RJ.

Cancer Res. 2013 Mar 15;73(6):1969-80. doi: 10.1158/0008-5472.CAN-12-1472. Epub 2013 Feb 1.

11.

Targeting the human kinome for cancer therapy: current perspectives.

Zhang L, Daly RJ.

Crit Rev Oncog. 2012;17(2):233-46. Review.

PMID:
22471710
12.

Tyrosine phosphorylation profiling reveals the signaling network characteristics of Basal breast cancer cells.

Hochgräfe F, Zhang L, O'Toole SA, Browne BC, Pinese M, Porta Cubas A, Lehrbach GM, Croucher DR, Rickwood D, Boulghourjian A, Shearer R, Nair R, Swarbrick A, Faratian D, Mullen P, Harrison DJ, Biankin AV, Sutherland RL, Raftery MJ, Daly RJ.

Cancer Res. 2010 Nov 15;70(22):9391-401. doi: 10.1158/0008-5472.CAN-10-0911. Epub 2010 Sep 21.

Supplemental Content

Loading ...
Support Center